genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Five Prime Therapeutics
Five Prime Eliminates 70 Jobs in Restructuring
News
CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System
Tech Exclusives
Blood Test to Diagnose Brain Cancer in Development
Neuroscience
Valium Soothes Best If Its Target Receptor Snuggles with Auxiliary Protein
News
UCB to Acquire Ra Pharma for $2.1B, Raising Rare Disease Presence
Insights
Commentary
Successfully Addressing the Challenges of Glycosylation
Brexit
Top 10 European Biopharma Clusters
Tech Exclusives
One-Stop-Shop Genome Editing Product Launched by Inscripta
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
October 2019 Vol. 39 No. 10
CRISPR Dx May Help Nix Disease
A-Lists
Brexit
Top 10 European Biopharma Clusters
Insights
Top 10 U.S. Biopharma Clusters
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
October 2019 Vol. 39 No. 10
Top 10 Companies Leveraging Gene Editing in 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Five Prime Therapeutics
Five Prime Eliminates 70 Jobs in Restructuring
News
CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System
Tech Exclusives
Blood Test to Diagnose Brain Cancer in Development
Neuroscience
Valium Soothes Best If Its Target Receptor Snuggles with Auxiliary Protein
Magazine
All
Supplement
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
October 2019 Vol. 39 No. 10
CRISPR Dx May Help Nix Disease
Tech Exclusives
Modular Bioprocessing Makes Adaptability a Snap
Tech Exclusives
A Nanomedicine Technology Sampler Pack
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
A Cultured Life: Innovations in Spheroid and Organoid Models
Posters
Microfluidic Diffusional Sizing: A Novel Method for Characterizing Protein Interactions
Drug Discovery
Importance of mAb Discovery and Development in Immunotherapy
eBooks
Sample Preparation for Quality Control: Solutions for Optimized Workflows and Accurate…
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Therapeutics
Respiratory Drugs
Respiratory Drugs
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Respiratory Drugs
Zambon Acquires Breath Therapeutics for Up-to-€500M, Adding to Respiratory Pipeline
Respiratory Drugs
Childhood Asthma Associated with Almost 3X as Many Genes as Adult Asthma
Respiratory Drugs
Influenza Drug Platform Could Yield Candidates for Multiple Pathogens
Respiratory Drugs
Fish Oil for Asthma? Don’t Hold Your Breath
Respiratory Drugs
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Respiratory Drugs
Vectura Scraps Asthma Drug-Device VR475 after Phase III Failure
Respiratory Drugs
Oily Fish Reduces Airway Inflammation in Asthmatic Children
Respiratory Drugs
AbbVie Takes Control of Cystic Fibrosis Collaboration with Galapagos
Respiratory Drugs
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
Respiratory Drugs
Cell Network Study Shines Light on Lung Cancer Signal Pathways
Respiratory Drugs
IL-26 Offers New Therapeutic Target for Chronic Smokers with Lung Disease
Respiratory Drugs
Common Cold Blocked from Replicating by Novel Drug Molecule
Respiratory Drugs
AstraZeneca Weighs Expanding Fasenra to COPD after Phase III Failure
Respiratory Drugs
Telomerase Gene Therapy Cures Pulmonary Fibrosis in Mice
Respiratory Drugs
Regeneron Genetics Center Surpasses 250K Exomes Sequenced, and Ramping Up
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
